Showing 381-390 of 2081 results for "".
ICD-10: Facts, Myths, and Solutions
https://practicaldermatology.com/topics/practice-management/facts-mythsand-solutions/21422/With the deadline for implementation of the new Medicare coding system just months away, physicians need to prepare their practices for a significant transition.Your EHR Server: Cloud vs. Hosted
https://practicaldermatology.com/topics/practice-management/your-ehr-server-cloud-vs-hosted/21606/While EHRs are shifting to cloud-based servers, clinicians should consider how each model suits their individual needs.Examining the Implications of Stage 2 of the EHR Incentive Program
https://practicaldermatology.com/topics/practice-management/examining-the-implications-of-stage-2-of-the-ehr-incentive-program/21564/Requirements for patient involvement via portals may spell headaches for physicians hoping to qualify for government incentives in 2014.Meet Dr. Google, The Dermatologist
https://practicaldermatology.com/topics/practice-management/meet-dr-google-the-dermatologist/23526/New Google app seeks to help patients identify skin woes.Current Sunscreen Controversies Impeding Patient Compliance
https://practicaldermatology.com/topics/practice-management/current-sunscreen-controversies-impeding-patient-compliance/20992/Patient concerns should not prevent the physician from advising adequate sunscreen use.DermWireTV: Derm Salaries Down, Allergan Eyes Soliton, Emsculpt Week
https://practicaldermatology.com/topics/practice-management/dermwiretv-derm-salaries-down-allergan-eyes-soliton-emsculpt-week/19941/Just under half of all physicians in the US are employed in physician-owned medical practices, new data from the American Medical Association show. Medscape’s annual Physician Compensation Report reveals that physicians overall saw a reduction in income due to the COVID-19 pandemic; income for dermDermWireTV: Sotyktu Approval, Cetaphil at 75, Psoriasis/Depression Link
https://practicaldermatology.com/topics/psoriasis/dermwiretv-sotyktu-approval-cetaphil-at-75-psoriasisdepression-link/20138/FDA has approved Bristol Myers Squibb’s Sotyktu (deucravacitinib) for the oral treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. April Armstrong, MD discusses the first TYK-2 inhibitor approved for psoriasis. As Cetaphil (Galderma)Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21861/Update on the Treatment of Actinic Keratoses
https://practicaldermatology.com/topics/general-topics/update-on-the-treatment-of-actinic-keratoses/21630/From mainstay therapies to newly approved agents, treatment options for actinic keratoses are growing.Take 5: Developments Toward Improved Skin Cancer Detection and Treatment
https://practicaldermatology.com/columns/take-5/take-5-developments-toward-improved-skin-cancer-detection-and-treatment/21895/Here's an update on various studies and developments regarding the management of cutaneous malignancies.